Reversal of Alzheimer's-like pathology and behavior in human APP transgenic mice by mutation of Asp664.

Proceedings of the National Academy of Sciences of the United States of America
Veronica GalvanDale E Bredesen

Abstract

The deficits characteristic of Alzheimer's disease (AD) are believed to result, at least in part, from the neurotoxic effects of beta-amyloid peptides, a set of 39-43 amino acid fragments derived proteolytically from beta-amyloid precursor protein (APP). APP also is cleaved intracytoplasmically at Asp-664 to generate a second cytotoxic peptide, APP-C31, but whether this C-terminal processing of APP plays a role in the pathogenesis of AD is unknown. Therefore, we compared elements of the Alzheimer's phenotype in transgenic mice modeling AD with vs. without a functional Asp-664 caspase cleavage site. Surprisingly, whereas beta-amyloid production and plaque formation were unaltered, synaptic loss, astrogliosis, dentate gyral atrophy, increased neuronal precursor proliferation, and behavioral abnormalities were completely prevented by a mutation at Asp-664. These results suggest that Asp-664 plays a critical role in the generation of Alzheimer-related pathophysiological and behavioral changes in human APP transgenic mice, possibly as a cleavage site or via protein-protein interactions.

References

May 1, 1984·Journal of Neuroscience Methods·R Morris
Jun 6, 1995·Proceedings of the National Academy of Sciences of the United States of America·P M MoranP C Moser
Dec 16, 1997·Proceedings of the National Academy of Sciences of the United States of America·C Sturchler-PierratB Sommer
Mar 17, 1999·Proceedings of the National Academy of Sciences of the United States of America·A Y HsiaL Mucke
Apr 28, 2000·Neurobiology of Disease·J C DodartA Ungerer
Jul 19, 2002·Journal of Neurochemistry·Veronica GalvanDale E Bredesen
Oct 26, 2002·Science·Dennis J Selkoe
Jan 29, 2003·Proceedings of the National Academy of Sciences of the United States of America·Jeffrey M RedwineFloyd E Bloom
Jul 26, 2003·Proceedings of the National Academy of Sciences of the United States of America·Jorge J PalopLennart Mucke
Oct 11, 2003·Journal of Neurochemistry·Daniel C LuEdward H Koo
Dec 9, 2003·Proceedings of the National Academy of Sciences of the United States of America·Kunlin JinDavid A Greenberg
Jun 16, 2004·Journal of Neuroscience Research·Wolfgang J Streit
Sep 2, 2004·Proceedings of the National Academy of Sciences of the United States of America·Kunlin JinDavid A Greenberg
Oct 21, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Jeannie ChinLennart Mucke

❮ Previous
Next ❯

Citations

Nov 6, 2007·Acta Neuropathologica·Richard C DavisMarcus Fechheimer
May 14, 2011·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Orso Bugiani
Jun 22, 2011·Journal of Molecular Neuroscience : MN·Karen S PoksayRammohan V Rao
Mar 22, 2013·Molecular Neurobiology·Santosh JadhavMichal Novak
May 15, 2013·Ageing Research Reviews·Carolina A OlivaNibaldo C Inestrosa
Feb 5, 2010·Lancet Neurology·Bruno A Bergmans, Bart De Strooper
Mar 9, 2011·Biochemistry·Sravanti Vaidya, Jeanne A Hardy
Jan 17, 2009·Cell Death and Differentiation·F C LourençoP Mehlen
Nov 17, 2010·Nature Chemical Biology·Benjamin G HoffstromBrent R Stockwell
Oct 22, 2011·Nature Reviews. Drug Discovery·Dagmar E EhrnhoeferMichael R Hayden
Oct 20, 2009·Proceedings of the National Academy of Sciences of the United States of America·Kaushik GhosalSanjay W Pimplikar
Jul 21, 2009·The Journal of Biological Chemistry·Juliette GafniLisa M Ellerby
Aug 15, 2012·The Journal of Biological Chemistry·Elih M Velázquez-Delgado, Jeanne A Hardy
Oct 30, 2008·The Journal of Biological Chemistry·Bruce A Yankner, Tao Lu
Aug 13, 2008·Human Molecular Genetics·Gorazd B StokinLawrence S B Goldstein
Feb 23, 2012·Cold Spring Harbor Perspectives in Medicine·Ulrike C Müller, Hui Zheng
Nov 4, 2006·Science·Erik D Roberson, Lennart Mucke
Nov 28, 2007·Annual Review of Pathology·Bruce A YanknerPatrick Loerch
Apr 17, 2012·International Journal of Alzheimer's Disease·Daniel A Bórquez, Christian González-Billault
Feb 18, 2010·Neuro-degenerative Diseases·Nikolaos K Robakis
Feb 12, 2011·The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry·Dagmar E EhrnhoeferMichael R Hayden
Aug 26, 2006·Molecular Neurodegeneration·Hui Zheng, Edward H Koo
Apr 30, 2011·Molecular Neurodegeneration·Hui Zheng, Edward H Koo
Jan 11, 2011·Molecular Brain·Yun-wu ZhangHuaxi Xu
May 28, 2013·Alzheimer's Research & Therapy·Scott J WebsterLinda J Van Eldik
Nov 26, 2010·PloS One·Alessia P M BarbagalloLuciano D'Adamio
Nov 12, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Rona K GrahamMichael R Hayden
Nov 24, 2012·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Sung W ChoiMartin D Brand
Feb 21, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Jessica E YoungAlbert R La Spada
Dec 18, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Andrzej SwistowskiDale E Bredesen
Jan 8, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Julie A HarrisLennart Mucke
May 25, 2013·EMBO Molecular Medicine·Dale E Bredesen, Varghese John
Feb 9, 2012·Journal of Amino Acids·D Allan Butterfield, Rukhsana Sultana
Apr 5, 2011·Annual Review of Neuroscience·Richard J O'Brien, Philip C Wong
May 9, 2014·Expert Opinion on Therapeutic Patents·Clive McCarthy, Edward Walker

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Animal Models

Alzheimer's disease is a neurodegenerative disease which can be studied using various experimental systems. This feed focuses on animal models used for Alzheimer's disease research.

Astrocytes & Amyloid

Astrocytes are thought to play a role in amyloid production and have been implicated in neurodegenerative diseases such as Alzheimer’s disease. Here is the latest research on the relationship between astrocytes and amyloid.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.

© 2022 Meta ULC. All rights reserved